Message #27 From:
Stock News Bot Date: October 6, 2006 04:44:00 AM
CLRI News Clearant Completes Successful Quarter with Record Number of Tissue Implants Distributed
LOS ANGELES--(BUSINESS WIRE)--Clearant, Inc. (OTCBB:CLRI) today announced that a record 52 Clearant
Sterile Implant® cervical spinal and soft
tissue allografts were distributed during the third quarter of 2006, the
first complete quarter since the Company began making Clearant Sterile
Implants available directly to surgeons and clinics.
“Based on the positive response from our
current and prospective customers, we expect the revenue from Clearant
Sterile Implants to continue to increase in the fourth quarter of 2006,”
said Clearant Chief Executive Officer Alain Delongchamp. “Awareness
and attention to sterilization is becoming more widespread within the
orthopedic surgeon community and we’re seeing
increasing demand for Clearant Sterile Implants.”
Demand for Clearant Sterile Implants continues to grow as evident by the
recent groundswell of interest from spinal surgeons that visited Clearant’s
exhibit booth at a national meeting of spinal surgeons held last week in
Seattle, WA. Numerous spinal surgeons at the program expressed a high
degree of interest in potentially converting their practices to the use
of Clearant Sterile Implants.
Mr. Delongchamp added, “We are very pleased
with the positive response that Clearant has received from spinal
surgeons with whom we met in Seattle and, more broadly, the surgeons and
medical community.”
About Clearant, Inc.
Clearant, Inc. is a leader in pathogen inactivation for biological
products. Clearant has developed the patent-protected Clearant Process,
which substantially reduces all types of bacteria and viruses in
biological products while maintaining the functionality of the
underlying tissue implant or protein. The Company began to distribute
directly to surgeons, hospitals and clinics Clearant Process sterile
implants in June 2006; in addition, Clearant continues to license the
Clearant Process and provides its patented sterilization services to
tissue banks and other biological products manufacturers. As of the end
of 1Q 2006, Clearant had 10 license and service agreements with tissue
banks. To date more than 8,000 patients have been successfully implanted
with Clearant Process sterile implants supplied by one of the Company's
licensed partners. Whereas various competing sterilization methods only
kill specific types of pathogens (such as bacteria or lipid-enveloped
viruses) for specific products, the Clearant Process reduces all types
of pathogens for products across many market segments including tissue
implants, plasma proteins, recombinant products, medical devices and
blood products. Also, the Clearant Process can be applied at various
stages of product processing and/or manufacturing, including in the
final packaging. For more information, please visit www.clearant.com.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in
this press release are forward looking and made pursuant to the Safe
Harbor provisions of the Private Securities Litigation Reform Act of
1995, in particular statements regarding surgeons strongly recommending
the use of implants with tissue treated by the CLEARANT PROCESS, and the
conclusions from a study by surgeons to build demand for sterilized
tissue.These forward-looking statements reflect numerous
assumptions and involve a variety of risks and uncertainties, many of
which are beyond the company's control, which may cause actual results
to differ materially from stated expectations. These risk factors
include, among others, limited operating history, difficulty in
developing, exploiting and protecting proprietary technologies, results
of additional clinical studies, acceptance and success of our direct
distribution of allografts, efficacy of the technology, intense
competition and substantial regulation in the biotechnology industry,
and additional risks discussed in the company's filings with the SEC,
available on the SEC web site http://www.sec.gov.
